BSE filing, NSE: BCLENTERPR. Summary written from the filing by ALFA Finder's alert engine.
BCL Enterprises Ltd: key numbers
- Share price
- ₹0.54
- Market cap
- ₹6.30 Cr
- Revenue (annual)
- ₹1.22 Cr
- Net profit (annual)
- ₹-5.88 Cr
- P/E (TTM)
- -0.6×Sector 19.7×
- Promoter holding
- 3.15%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from BCL Enterprises Ltd
All →BCL Enterprises Annual General Meeting
BCL Enterprises Limited conducted its 41st Annual General Meeting on September 28, 2026. Shareholders approved the adoption of financial statements and the re-appointment of directors and auditors.
BCL Enterprises Other Announcement
BCL Enterprises informed shareholders about accessing the 41st AGM Notice and Annual Report online and reiterated mandatory KYC update requirements for physical security holders.
BCL Enterprises Annual General Meeting
BCL Enterprises Limited issued the notice for its Annual General Meeting to be held on September 28, 2026. The agenda includes adoption of financial statements and director appointments.
BCL Enterprises Annual Report
BCL Enterprises Limited scheduled its 41st Annual General Meeting for September 28, 2026. The company also submitted its Annual Report for the financial year 2025-26.
BCL Enterprises Management Change
BCL Enterprises Limited announced the resignation of Mr. Jeevan Singh Rana from his position as a Non-Executive Independent Director, effective September 1, 2026.
BCL Enterprises Board Meeting Outcome
The Board approved several governance appointments, including a new Internal Auditor, Company Secretary, and re-appointed the Managing Director. It also scheduled the AGM for September 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.